Click on a field for details on how to access that data via Web API, Excel, or CSV File Download.
Open Price | |
High Price | |
Low Price | |
Close Price | |
Change | |
Percent Change | |
Volume |
Avg Daily Volume | 1,179,642 |
52 Week High | $11.43 |
52 Week Low | $6.18 |
Target Price | N/A |
Ticker | ELOS:UW |
Composite Ticker | ELOS:US |
Security Name | Syneron Medical Ltd |
Type | Ordinary Shares |
Class | ELOS |
Currency | USD |
Round Lot Size | 100 |
Primary | Yes |
Delisted | Yes |
ETF | No |
Market Category | Common Stock |
Market Sector | N/A |
Exchange Symbol | ^USCOMP |
Exchange Name | US COMPOSITE |
Exchange City | N/A |
Exchange Country | UNITED STATES OF AMERICA |
Exchange Website | N/A |
FIGI | BBG000Q4S0H3 |
Composite FIGI | BBG000Q4RSL8 |
Share Class FIGI | BBG001SJY3J1 |
FIGI Unique ID | EQ0000000001220816 |
Dividend | N/A |
Dividend Rate | N/A |
Trailing Dividend Yield | 0.00% |
5-year Average Dividend Yield | 0.00% |
Dividend Ex Date | N/A |
Beta | 1.0797 |
1-year beta | 1.1628 |
3-year beta | 1.0797 |
5-year beta | 1.1222 |
7-year beta | 1.1945 |
10-year beta | 1.1249 |
Syneron Medical Ltd., together with its subsidiaries, researches, develops, manufactures, markets, and sells aesthetic medical products worldwide. The company develops products based on its proprietary Electro-Optical Synergy technology, which uses the synergy between electrical energy and optical energy to provide aesthetic medical treatments. It offers products, which are used for various non-invasive aesthetic medical procedures, including hair removal, wrinkle reduction, rejuvenation of the skin's appearance through the treatment of superficial benign vascular and pigmented lesions, acne treatment, treatment of leg veins, treatment for the temporary reduction in the appearance of cellulite and thigh circumference, ablation and resurfacing of the skin, laser-assisted lipolysis, and tattoo removal. The company also provides cosmetic and aesthetic lasers, and light-based systems used by physicians and personal care practitioners; non-invasive technologies for fat cell destruction and body sculpting; and Viador system, a handheld device with a radiofrequency-needle array for use in transdermal delivery of biologic drug-products through a system-specific skin patch. It sells its products to dermatologists, plastic surgeons, other cosmetic physicians, qualified practitioners, and aestheticians and medical spas through direct sales force and distributors; and directly to end-users. Syneron Medical Ltd. was founded in 2000 and is headquartered in Yokneam Illit, Israel.